Cargando…

The place of ARBs in heart failure therapy: is aldosterone suppression the key?

Since the launch of the first orally available angiotensin II (AngII) type 1 receptor (AT(1)R) blocker (ARB) losartan (Cozaar) in the late 1990s, the class of ARBs (or ‘sartans’, short for Angiotensin-RecepTor-ANtagonistS) quickly expanded to include candesartan, eprosartan, irbesartan, valsartan, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markan, Uma, Pasupuleti, Samhitha, Pollard, Celina M., Perez, Arianna, Aukszi, Beatrix, Lymperopoulos, Anastasios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691655/ https://www.ncbi.nlm.nih.gov/pubmed/31401939 http://dx.doi.org/10.1177/1753944719868134

Ejemplares similares

Angiotensin receptor blocker drugs and inhibition of adrenal beta-arrestin-1-dependent aldosterone production: Implications for heart failure therapy
por: Lymperopoulos, Anastasios, et al.
Publicado: (2017)

Suppression of adrenal βarrestin1-dependent aldosterone production by ARBs: head-to-head comparison
por: Dabul, Samalia, et al.
Publicado: (2015)

Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition
por: Maning, Jennifer, et al.
Publicado: (2020)

Correction: Maning et al. Antagonistic Roles of GRK2 and GRK5 in Cardiac Aldosterone Signaling Reveal GRK5-Mediated Cardioprotection via Mineralocorticoid Receptor Inhibition. Int. J. Mol. Sci. 2020, 21, 2868
por: Maning, Jennifer, et al.
Publicado: (2021)

OR24-03 GRK2 Mediates Beta-Adrenergic Receptor Crosstalk to Enhanced Adrenocortical AngII-Dependent Aldosterone Production
por: Lymperopoulos, Anastasios, et al.
Publicado: (2020)

GRK2-Mediated Crosstalk Between β-Adrenergic and Angiotensin II Receptors Enhances Adrenocortical Aldosterone Production In Vitro and In Vivo
por: Pollard, Celina M., et al.
Publicado: (2020)

Adrenal βarrestin1 targeting for tobacco–associated cardiac dysfunction treatment: Aldosterone production as the mechanistic link
por: Solesio, Maria E, et al.
Publicado: (2019)

On the top of ARB N/L type Ca channel blocker leads to less elevation of aldosterone
por: Konoshita, Tadashi, et al.
Publicado: (2016)

Not all arrestins are created equal: Therapeutic implications of the functional diversity of the β-arrestins in the heart
por: Lymperopoulos, Anastasios, et al.
Publicado: (2019)

Aldosterone antagonism in heart failure
por: Miller, Alan B
Publicado: (2007)

Current and future G protein-coupled receptor signaling targets for heart failure therapy
por: Siryk-Bathgate, Ashley, et al.
Publicado: (2013)

Cardiac RGS Proteins in Human Heart Failure and Atrial Fibrillation: Focus on RGS4
por: Borges, Jordana I., et al.
Publicado: (2023)

Aldosterone and aldosterone receptor antagonists in patients with chronic heart failure
por: Nappi, Jean M, et al.
Publicado: (2011)

Sodium balance, circadian BP rhythm, heart rate variability, and intrarenal renin–angiotensin–aldosterone and dopaminergic systems in acute phase of ARB therapy
por: Isobe‐Sasaki, Yukako, et al.
Publicado: (2017)

Impact of Aldosterone on the Failing Myocardium: Insights from Mitochondria and Adrenergic Receptors Signaling and Function
por: Guitart-Mampel, Mariona, et al.
Publicado: (2021)

GRK5 is an essential co-repressor of the cardiac mineralocorticoid receptor and is selectively induced by finerenone
por: Pollard, Celina M, et al.
Publicado: (2022)

Carvedilol Selectively Stimulates βArrestin2-Dependent SERCA2a Activity in Cardiomyocytes to Augment Contractility
por: Maning, Jennifer, et al.
Publicado: (2022)

Novel Insights into the Crosstalk between Mineralocorticoid Receptor and G Protein-Coupled Receptors in Heart Adverse Remodeling and Disease
por: Parker, Barbara M., et al.
Publicado: (2018)

In silico prediction of ARB resistance: A first step in creating personalized ARB therapy
por: Anderson, Shane D., et al.
Publicado: (2020)

Efficacy and safety of sacubitril/valsartan in heart failure compared to renin–angiotensin–aldosterone system inhibitors: a systematic review and meta-analysis of randomised controlled trials
por: Hernandez, Adrian V., et al.
Publicado: (2023)

The effects of ACEI/ARB, aldosterone receptor antagonists and statins on preventing recurrence of atrial fibrillation: A protocol for systematic review and network meta-analysis
por: Jia, Qiulei, et al.
Publicado: (2021)

Renin-angiotensin-aldosterone system and kidney interactions in heart failure
por: Ferreira, João Pedro, et al.
Publicado: (2019)

Incidental Congestive Heart Failure in Patients With Aldosterone‐Producing Adenomas
por: Huang, Wei‐Chieh, et al.
Publicado: (2019)

The renin–angiotensin–aldosterone-system and right heart failure in congenital heart disease
por: Andersen, Stine, et al.
Publicado: (2016)

From ARB to ARNI in Cardiovascular Control
por: Uijl, Estrellita, et al.
Publicado: (2016)

Repurposing ARBs as treatments for breast cancer
por: George, Amee J., et al.
Publicado: (2017)

The histological spectrum of ARB‐induced gastritis
por: Storozuk, Tanner, et al.
Publicado: (2022)

Need to Revisit Step Therapy for ARBs
por: Ram, C. Venkata, et al.
Publicado: (2007)

Deletion of Osteopontin Enhances β(2)-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes
por: Pollard, Celina M., et al.
Publicado: (2019)

Structure–activity relationship study of angiotensin II analogs in terms of β‐arrestin‐dependent signaling to aldosterone production
por: Valero, Thairy Reyes, et al.
Publicado: (2016)

From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy
por: Matsoukas, John, et al.
Publicado: (2021)

Efficacy of ARB/HCTZ Combination Therapy in Uncontrolled Hypertensive Patients Compared with ARB Monotherapy: A Meta-Analysis
por: Ma, Linlin, et al.
Publicado: (2021)

Myocardial Effects of Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction
por: McDiarmid, Adam K., et al.
Publicado: (2019)

Diabetes and Excess Aldosterone Promote Heart Failure With Preserved Ejection Fraction
por: Hegyi, Bence, et al.
Publicado: (2022)

Nicotine-induced adrenal beta-arrestin1 upregulation mediates tobacco-related hyperaldosteronism leading to cardiac dysfunction
por: Cora, Natalie, et al.
Publicado: (2020)

Physiology and pharmacology of the cardiovascular adrenergic system
por: Lymperopoulos, Anastasios
Publicado: (2013)

Editorial to the IJMS Special Issue on Sglt2 Inhibitors Vol. 1
por: Lymperopoulos, Anastasios
Publicado: (2023)

Awareness of physicians and pharmacists of aldosterone antagonists in heart failure and myocardial infarction in Jordan
por: Mayyas, Fadia, et al.
Publicado: (2017)

Clinical determinants and prognostic implications of renin and aldosterone in patients with symptomatic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2020)

Proanthocyanidins Maintain Cardiac Ionic Homeostasis in Aldosterone-Induced Hypertension and Heart Failure
por: de las Heras, Natalia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l0fefr3hdg4vb17452s9p3t38g